评估非药理学多因素干预措施对老年患者认知障碍的有效性
Jiajia Cui1, Junjun Zhu1, Yanbin Wei2
1Department of Geriatrics, Lishui Second People's Hospital, No. 69, North Ring Road, Liandu District, Lishui, Zhejiang Province, China.
Pakistan journal of pharmaceutical sciences
|June 25, 2025
概括
一种非药理学多因素方法改善了老年人的认知功能. 这种干预改善了老年人的认知状态 (MMSE,MoCA),身体健康和整体生活质量.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 认知能力下降是老年人群的一个重大问题.
- 现有的治疗方法往往集中在单一因素上,可能会限制疗效.
- 多因素方法可能为认知障碍提供更全面的解决方案.
研究的目的:
- 评估对老年人认知衰退的非药理学,多因素干预措施的有效性.
- 评估干预对认知功能,身体表现,情绪和营养状况的影响.
- 为了确定患者满意度和护理人员负担的变化.
主要方法:
- 一项前性队列研究,涉及120名患有认知障碍的老年患者 (≥65岁).
- 干预包括学习任务,解决问题,运动活动,社会参与和饮食修改.
- 使用迷你精神状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA) 评估的认知功能.
- 身体表现 (定时启动和启动测试 - TUG),抑郁 (老年抑郁量表 - GDS) 和营养状况 (BMI,血液样本) 也被测量.
- 后续评估每3个月进行一次,持续一年.
主要成果:
- 在认知功能中观察到显著的改善:在12个月后,MMSE的平均增加为4.0分,MoCA的平均增加为3.8分.
- 在身体健康,抑郁水平,营养状况,社会融合和睡眠质量方面发现了积极的变化.
- 患者满意度增加,护理人员负担显著下降.
- 多因素方法在提高认知功能和生活质量方面表现出有效性.
结论:
- 非药物,多因素干预可以有效地改善老年人的认知功能.
- 同时解决多种风险因素可以促进老年人的更好的认知健康和整体幸福感.
- 这种方法为管理认知衰退和改善老年人群的生活质量提供了一个有希望的策略.
更多相关视频
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.0K
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.9K
相关概念视频
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214
01:30Cognitive Development During Adulthood
303
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
303
01:26Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684